Monogram Biosciences to Present at the JMP Securities Healthcare Conference

Tuesday, September 30, 2008 General News J E 4
SOUTH SAN FRANCISCO, Calif., Sept. 29 MonogramBiosciences, Inc. (Nasdaq: MGRM) announced today that Alfred G. Merriweather,Senior Vice President and Chief Financial Officer, is scheduled to present acorporate overview at the JMP Securities' Third Annual Healthcare FocusConference on Tuesday, October 7 at 8:30 a.m. (Eastern Time) at Le ParkerMeridien Hotel in New York City.

To access the live audio broadcast or the subsequent archived recording,log on to and go to the investor relations section("Investors/Media" tab) and click on the "Events & Webcasts" link provided onthe sidebar menu on the page.

About Monogram Biosciences, Inc.

Monogram is advancing individualized medicine by discovering, developingand marketing innovative products to guide and improve treatment of seriousinfectious diseases and cancer. The Company's products are designed to helpdoctors optimize treatment regimens for their patients that lead to betteroutcomes and reduced costs. The Company's technology is also being used bynumerous biopharmaceutical companies to develop new and improved antiviraltherapeutics and vaccines as well as targeted cancer therapeutics. Moreinformation about the Company and its technology can be found on its web siteat Alfred G. Merriweather Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare Tel: 650 624-4576 Tel: 415 677-2700 amerriweather@ jeremiah.hall@

SOURCE Monogram Biosciences, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Delaware Man Spearheads Brain Tumor Awareness
Siemens Announces Government Contract to Develop L...